selected publications
-
PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo-controlled trial.
The Journal of infectious diseases.
2005
Academic Article
GET IT
Times cited: 83 -
Cervicovaginal secretions contribute to innate resistance to herpes simplex virus infection.
The Journal of infectious diseases.
2005
Academic Article
GET IT
Times cited: 65 -
Candidate topical microbicides bind herpes simplex virus glycoprotein B and prevent viral entry and cell-to-cell spread.
Antimicrobial agents and chemotherapy.
2004
Academic Article
GET IT
Times cited: 93